Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Sign in
Sign in

Biogen board approves spin-off of hemophilia business

The board of directors of US biotech Biogen (Nasdaq: BIIB) has approved the spin-off of its hemophilia business, which will be known as Bioverativ Inc.

A special dividend distribution of all of the outstanding shares of Bioverativ common stock has also been declared so that for every two Biogen shares held on January 17, shareholders will receive one share in the new company. Registered shareholders will receive cash in lieu of fractional shares.

The distribution of Bioverativ common stock will complete the proposed separation of the hemophilia business from Biogen, plans for which were first revealed in May after being discussed for some time.

After the separation, Bioverativ will become an independent, publicly-traded company with the ticker symbol Nasdaq: BIVV, focused on hemophilia and other rare blood disorders, and Biogen will retain no ownership interest.

Biogen’s outgoing chief executive George Scangos, whose replacement was named this week, said: “Today's announcement is a significant milestone toward the creation of two independent global biotechnology companies, each of which will be focused on transforming the lives of patients in distinct areas.”

The new company will be anchored by the drugs Eloctate [antihemophilic Factor (recombinant), Fc fusion protein] for hemophilia A and Alprolix (coagulation Factor IX [recombinant]) for hemophilia B, which last year generated in $320 million and $235 million in sales, respectively.

21-12-2016

Source: http://www.thepharmaletter.com/

0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies